Financials
Financial year 2025
Osteolab from Zwevegem, company number BE0687836007, closed financial year 2025 with a result of € 100,116 after tax. For that financial year Osteolab recorded a gross margin of € 177,527 and equity of € 140,616. Compared with financial year 2024, the result moved from € 83,802 to € 100,116. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 26, 2026.
€ 140,616
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 100,116
▲ 19% vs 2024
Profit after tax over the fiscal year.
€ 6,503
▲ 84% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 100,000 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 5,063
▼ 3% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 191,319
▼ 15% vs 2024
€ 25,930 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 7,437
▲ 58% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 315
▼ 89% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 123,392 | € 149,549 | € 159,647 | € 177,527 | ▲ 11% |
| Profit after taxes | € 54,562 | € 73,232 | € 83,802 | € 100,116 | ▲ 19% |
| Equity | € 83,466 | € 116,698 | € 140,500 | € 140,616 | |
| Total debts | € 336,614 | € 305,706 | € 293,992 | € 307,363 | ▲ 5% |
| Cash | € 15,523 | € 13,768 | € 3,538 | € 6,503 | ▲ 84% |
| Land & buildings | € 270,262 | € 253,035 | € 236,814 | € 219,535 | ▼ 7% |
| Retained profit | € 64,866 | € 98,098 | € 121,900 | € 122,016 | |
| Dividend | € 40,000 | € 40,000 | € 60,000 | € 100,000 | ▲ 67% |
| Bank debt | € 284,367 | € 254,928 | € 223,998 | € 191,319 | ▼ 15% |
| Balance sheet total | € 420,080 | € 422,404 | € 434,492 | € 447,979 | ▲ 3% |
Key figures of Osteolab, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Osteolab?
What happened at Osteolab in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 100,116 (▲ 19% vs 2024). Source: NBB ↗
- New establishment in Zwevegem. KBO
- Start of the company according to the CBE. KBO
- Egwin Ponette became a director. NBB
In short
From € 54,562 profit in 2022 to € 100,116 profit in 2025.
Paid € 92,052 in corporate taxes since 2022.
Best year ever: 2025, with € 100,116 profit.
Paid out € 240,000 in dividends to the owners in total.
Management
Behind Osteolab is Egwin Ponette. Egwin Ponette is also behind PHARMANUTRICS INTERNATIONAL, PharmaNutrics and AV Medical.
Directors
According to the 2025 annual accounts
since 2018
Establishments
Establishment units
Physical locations of this company
Otegemstraat(Z) 198
8550 Zwevegem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0687.836.007
- VAT number
- BE 0687.836.007
- Registered office
- Otegemstraat(Z) 198, 8550 Zwevegem
- Names & denominations
- Osteolab
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 January 2018
- Peppol
- Active · Active since 12 Feb 2025
- Activities · NACE
Activiteiten van medisch specialisten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering